Clinical characteristics and risk factors associated with secondary bloodstream infection in patients with intensive care unit-acquired pneumonia due to carbapenem-resistant Klebsiella pneumoniae

Chin Med J (Engl). 2021 Jul 20;134(14):1735-1737. doi: 10.1097/CM9.0000000000001444.

Authors

Xin-Yun Zhu¹, Hong-Bin Wang², Ye-Han Zhu¹, Yan-Bin Chen¹, Bei-Lei Zhang¹, Cheng Chen¹

Affiliations

¹ Department of Respiratory and Critical Medicine, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, China.
² Institute of Respiratory Diseases, Soochow University, Suzhou, Jiangsu 215006, China.

No abstract available

MeSH terms

Anti-Bacterial Agents / pharmacology
Anti-Bacterial Agents / therapeutic use
Bacteremia*
Carbapenems / therapeutic use
Cross Infection* / drug therapy
Drug Resistance, Bacterial
Humans
Intensive Care Units
Klebsiella Infections* / drug therapy
Klebsiella pneumoniae
Pneumonia* / drug therapy
Risk Factors

Substances

Anti-Bacterial Agents
Carbapenems